Evidence map›Paper›PMID 39532893›Full record

ArticleNature communications2024

Mechanics-activated fibroblasts promote pulmonary group 2 innate lymphoid cell plasticity propelling silicosis progression.

Yangyang He, Fan Yang, Lin Yang, Haoyang Yuan, Yichuan You, Yinghui Chen, Xiulin Wu, Hui Min, Jie Chen, Chao Li

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Multi-omics reveals a novel Cxcr4Clinical and translational medicine · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Tools of the trade: leveraging 3DFrontiers in pharmacology · 2026
    Review
  10. Article
  11. Review
  12. The importance of mechanical forces in chronic respiratory diseases.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yangyang He *Key Laboratory of Environmental Stress and Chronic Disease Control & Prevention (China Medical University), Ministry of Education, Shenyang, Liaoning, PR China.ORCID 0009-0005-5793-4570
Fan Yang *Key Laboratory of Environmental Stress and Chronic Disease Control & Prevention (China Medical University), Ministry of Education, Shenyang, Liaoning, PR China.ORCID 0009-0009-8830-6154
Lin YangKey Laboratory of Environmental Stress and Chronic Disease Control & Prevention (China Medical University), Ministry of Education, Shenyang, Liaoning, PR China.ORCID 0009-0006-9595-6356
Haoyang YuanKey Laboratory of Environmental Stress and Chronic Disease Control & Prevention (China Medical University), Ministry of Education, Shenyang, Liaoning, PR China.ORCID 0009-0003-8108-8082
Yichuan YouKey Laboratory of Environmental Stress and Chronic Disease Control & Prevention (China Medical University), Ministry of Education, Shenyang, Liaoning, PR China.ORCID 0009-0007-0837-0013
Yinghui ChenKey Laboratory of Environmental Stress and Chronic Disease Control & Prevention (China Medical University), Ministry of Education, Shenyang, Liaoning, PR China.ORCID 0009-0006-9921-5096
Xiulin WuKey Laboratory of Environmental Stress and Chronic Disease Control & Prevention (China Medical University), Ministry of Education, Shenyang, Liaoning, PR China.ORCID 0009-0008-5551-0792
Hui MinDepartment of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang, Liaoning, PR China.ORCID 0000-0003-2667-7864
Jie ChenKey Laboratory of Environmental Stress and Chronic Disease Control & Prevention (China Medical University), Ministry of Education, Shenyang, Liaoning, PR China. jchen@cmu.edu.cn.ORCID 0000-0002-5183-4852
Chao LiKey Laboratory of Environmental Stress and Chronic Disease Control & Prevention (China Medical University), Ministry of Education, Shenyang, Liaoning, PR China. lichao@cmu.edu.cn.ORCID 0000-0001-5723-1414

Funding

National Natural Science Foundation of China (National Science Foundation of China) No.82173490
6 · The paper itself

Abstract

Crystalline silica (CS) particle exposure leads to silicosis which is characterized as progressive fibrosis. Fibroblasts are vital effector cells in fibrogenesis. Emerging studies have identified immune sentinel roles for fibroblasts in chronic disease, while their immune-modulatory roles in silicosis remain unclear. Herein, we show that group 2 innate lymphoid cell (ILC2) conversion to ILC1s is closely involved in silicosis progression, which is mediated by activated fibroblasts via interleukin (IL)-18. Mechanistically, Notch3 signaling in mechanics-activated fibroblasts modulates IL-18 production via caspase 1 activity. The mouse-specific Notch3 knockout in fibroblasts retards pulmonary fibrosis progression that is linked to attenuated ILC conversion. Our results indicate that activated fibroblasts in silicotic lungs are regulators of ILC2-ILC1 conversion, associated with silicosis progression via the Notch3-IL-18 signaling axis. This finding broadens our understanding of immune-modulatory mechanisms in silicosis, and indicates potential therapeutic targets for lung fibrotic diseases.

Indexed as

Disease ProgressionFibroblastsImmunity, InnateInterleukin-18LungLymphocytesMice, Inbred C57BLMice, KnockoutSilicosisAnimalsHumansMaleMicePulmonary FibrosisSignal TransductionSilicon DioxideInterleukin-18Silicon Dioxide

Identifiers

PMID39532893
PMCPMC11557922

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.